title: Database of T cell-defined human tumor antigens: the 2013 update.
abstract: The plethora of tumor antigens that have been--and are still being--defined required systematization to provide a comprehensive overview of those tumor antigens that are the most relevant targets for cancer immunotherapy approaches. Here, we provide a new update of a peptide database resource that we initiated many years ago. This database compiles all human antigenic peptides described in the literature that fulfill a set of strict criteria needed to ascertain their actual "tumor antigen" nature, as we aim at guiding scientists and clinicians searching for appropriate cancer vaccine candidates (www.cancerimmunity.org/peptide). In this review, we revisit those criteria in light of recent findings related to antigen processing. We also introduce the 29 new tumor antigens that were selected for this 2013 update. Two of the new peptides show unusual features, which will be briefly discussed. The database now comprises a total of 403 tumor antigenic peptides.
authors.affiliation: Ludwig Institute for Cancer Research, Brussels Branch, Brussels, Belgium.
authors.forename: Nathalie
authors.initials: N
authors.lastname: Vigneron
authors.forename: Vincent
authors.initials: V
authors.lastname: Stroobant
authors.forename: Benoît J
authors.initials: BJ
authors.lastname: Van den Eynde
authors.forename: Pierre
authors.initials: P
authors.lastname: van der Bruggen
mesh_terms: D000951:Antigens, Neoplasm / Q000276:immunology*; D016208:Databases, Factual; D006801:Humans; D010455:Peptides / Q000276:immunology; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology*
chemical_list: D000951:Antigens, Neoplasm; D010455:Peptides
keywords: CD4; CD8; HLA; T cell; database; peptide